Apieron inhales funds for asthma monitor
Apieron, maker of a device that monitors asthmatic conditions, has brought in an undisclosed sum in a fourth round of financing from existing investors Alliance Technology Ventures, Canaan Partners, Draper Fisher Jurvetson and Onset Ventures. Based in Menlo Park, Calif., the company says its lead… Continue Reading
Apieron seeks $25M under new leadership
Apieron Inc. plans to score $25 million in its currently open fourth-round of funding to advance development and build up sales of an asthma monitoring device.
This round is the first of Holly McGarraugh’s brand new tenure as president and chief executive officer. She joined the… Continue Reading
Life sciences briefing: Monday, Nov. 12, 2007
(UPDATED: See below.)
Featured companies: Anaptys Biosciences, Arterial Remodeling Technologies, Cambria Biosciences, CaseNet, ChemoCentryx, Ensemble Discovery, MediQuest, Piedmont Pharmaceuticals, Raven Biotechnologies, Sensys Medical, Verus Pharmaceuticals, Xanodyne Pharmaceuticals
UPDATED: Expanded items on Anaptys, Arterial Remodeling, Raven Biotech, Sensys and MediQuest. Moved ChemoCentryx and Xanodyne to a separate item.
Antibody-drug maker Raven Biotech… Continue Reading